RecipharmCobra Biologics names commercial director

Monday, August 1, 2011 12:29 PM

RecipharmCobra Biologics, the international manufacturer of biopharmaceuticals, has named Julian Hanak its commercial director. Julian will join the RecipharmCobra management team to build on the company’s growth in provision of manufacturing services for the biotech and biopharmaceutical industry.

Formerly at Renovo, Julian gained senior management and commercial experience as senior vice president of development. Julian previously worked at RecipharmCobra Biologics’ Keele facility for 11 years progressing from senior scientist to director of production.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs